Copernicus Capital Management, LLC - Q1 2021 holdings

$6.19 Million is the total value of Copernicus Capital Management, LLC's 14 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .

 Value Shares↓ Weighting
REGN NewREGENERON PHARMACEUTICALS$710,0001,500
+100.0%
11.47%
RVMD NewREVOLUTION MEDICINES INC$459,00010,000
+100.0%
7.42%
GRTS NewGRITSTONE ONCOLOGY INC$349,00037,000
+100.0%
5.64%
ARDX NewARDELYX INC$331,00050,000
+100.0%
5.35%
RCUS NewARCUS BIOSCIENCES INC$281,00010,000
+100.0%
4.54%
BCEL NewATRECA INC$276,00018,000
+100.0%
4.46%
ORTX NewORCHARD THERAPEUTICS PLCads$109,00015,000
+100.0%
1.76%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC15Q2 202128.6%
THERMO FISHER SCIENTIFIC INC10Q3 202113.8%
ZOETIS INC10Q1 202013.0%
FATE THERAPEUTICS INC9Q3 202113.7%
ILLUMINA INC9Q4 201911.8%
BIOMARIN PHARMACEUTICAL INC8Q3 202114.7%
BRISTOL-MYERS SQUIBB CO8Q4 202012.2%
INTUITIVE SURGICAL INC7Q2 201911.8%
STRYKER CORP7Q2 201911.6%
IQVIA HLDGS INC7Q4 20208.2%

View Copernicus Capital Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-14
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14

View Copernicus Capital Management, LLC's complete filings history.

Compare quarters

Export Copernicus Capital Management, LLC's holdings